side effects of glp-1 receptor agonists Safety and Tolerability Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs GI Adverse Effects of Glucagon-Like

Based on recent studies, SGLT2 inhibitors (SGLTis) are generally considered superior to GLP-1 receptor agonists (GLP-1s) for slowing the progression of chronic kidney disease

First, GLP-1RA can activate the first messenger adenylate cyclase (AC) after binding to the receptor, which stimulates an increase in the secretion level of the intracellular second messenger cyclic adenosine phosphate (cAMP) and subsequently activates the intracellular secondary messenger protein kinase A (PKA) (48)

Weight loss becomes measurable, though typically modest (2 to 4 pounds)

Asia Pacific 14.2.4

The relevance of these findings to humans is unknown

However, the challenge with current TRPV1 antagonists lies in their associated adverse effects, such as hyperthermia 24,25,26,27,28,29,30,31 and hypothermia 32,33,34 , caused by failures in thermoregulation